Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity.

Authors: Joachim Rudolph, William P. Esler, Stephen O'Connor, Philip D. G. Coish, Philip L. Wickens, Michael Brands, Donald E. Bierer, Brian T. Bloomquist, Georgiy Bondar, Libing Chen, Chih-Yuan Chuang, Thomas H. Claus, Zahra Fathi, Wenlang Fu, Uday R. Khire, James A. Kristie, Xiao-Gao Liu, Derek B. Lowe, Andrea C. McClure, Martin Michels

Source: Journal of Medicinal Chemistry; Oct2007, Vol. 50 Issue 21, p5202-5216, 15p